Abstract:Abstract Motivation Chemical–genetic interaction profiling is a genetic approach that quantifies the susceptibility of a set of mutants depleted in specific gene product(s) to a set of chemical compounds. With the recent advances in artificial intelligence, chemical–genetic interaction profiles (CGIPs) can be leveraged to predict mechanism of action of compounds. This can be achieved by using machine learning, where the data from a CGIP is fed into the machine learning platform along with the chemical descriptors to develop a chemogenetically trained model. As small molecules can be considered non-structural data, graph convolutional neural networks, which can learn from the chemical structures directly, can be used to successfully predict molecular properties. Clustering analysis, on the other hand, is a critical approach to get insights into the underlying biological relationships between the gene products in the high-dimensional chemical-genetic data. Methods and results In this study, we proposed a comprehensive framework based on the large-scale chemical-genetics dataset built in Mycobacterium tuberculosis for predicting CGIPs using graph-based deep learning models. Our approach is structured into three parts. First, by matching M. tuberculosis genes with homologous genes in Escherichia coli ( E. coli ) according to their gene products, we grouped the genes into clusters with distinct biological functions. Second, we employed a directed message passing neural network to predict growth inhibition against M. tuberculosis gene clusters using a collection of 50,000 chemicals with the profile. We compared the performance of different baseline models and implemented multi-label tasks in binary classification frameworks. Lastly, we applied the trained model to an externally curated drug set that had experimental results against M. tuberculosis genes to examine the effectiveness of our method. Overall, we demonstrate that our approach effectively created M. tuberculosis gene clusters, and the trained classifier is able to predict activity against essential M. tuberculosis targets with high accuracy. Conclusion This work provides an analytical framework for modeling large-scale chemical-genetic datasets for predicting CGIPs and generating hypothesis about mechanism of action of novel drugs. In addition, this work highlights the importance of graph-based deep neural networks in drug discovery.

Theoretical Approaches to the Prediction of the Biological Targets of Small-Molecular Compounds Based on Chemogenomic Information

Methods to Profile the Macromolecular Targets of Small Compounds.

Current Advances in Ligand‐based Target Prediction

A Survey On The Computational Approaches To Identify Drug Targets In The Postgenomic Era

In-silico Target Prediction by Ensemble Chemogenomic Model Based on Multi-Scale Information of Chemical Structures and Protein Sequences.

Predicting Biological Functions of Compounds Based on Chemical-Chemical Interactions

Using Bioinformatics for Drug Target Identification from the Genome

Virtual Screening on Natural Products for Discovering Active Compounds and Target Information

Kernel methods for in silico chemogenomics

Recent advances and method development for drug target identification

Prediction of drug-target interactions for drug repositioning only based on genomic expression similarity

Predicting Targeted Polypharmacology for Drug Repositioning and Multi- Target Drug Discovery

Therapeutic Target Identification and Drug Discovery Driven by Chemical Proteomics

drug-target prediction tool through the integration of chemogenomic data and clustering analysis

[Chemical Proteomics and Discovery of Drug Targets].

Prediction of molecular targets of cancer preventing flavonoid compounds using computational methods.

Similarity-based machine learning methods for predicting drug-target interactions: a brief review.

Chemical-Protein Interactome and Its Application in Off-Target Identification

MDTips: A Multimodal-data based Drug-Target interaction prediction system fusing knowledge, gene expression profile and structural data

Progress of methodology for identifying target protein of natural active small molecules

Deep learning-driven prediction of drug mechanism of action from large-scale chemical-genetic interaction profiles